CClinicalTrials.gg
CompletedNCT02841163Updated Jul 26, 2022

Disc Resorption in Lumbar and Cervical Disc Herniation Patients Receiving Integrative Korean Medicine Treatment

An observational study in Lumbar Intervertebral Disc Displacement and Cervical Intervertebral Disc Displacement, sponsored by Jaseng Medical Foundation. Completed at 1 site in Korea, Republic of. Per ClinicalTrials.gov, last updated 2022-07-26.

Sponsored by Jaseng Medical Foundation · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
505
Sex
All
01

Study summary

Measurement of herniated disc resorption and assessment of satisfaction regarding post-treatment state and integrative Korean medicine treatment through phone interview in 500 patients with MRI follow-up results receiving treatment for lumbar and cervical disc herniation at Jaseng Hospital of Korean Medicine.

Read the detailed description

Intervertebral disc herniation treatment can be largely divided into conservative and surgical approaches, and the greater majority of patients show relief of symptoms and resorption of herniated disc through non-surgical, conservative management. Despite concerns that early surgical interventions in intervertebral disc herniation without allowing for sufficient conservative treatment may indicate overtreatment, awareness and understanding in the general public is found somewhat lacking.

The objective of this study is to measure herniated disc resorption and assess satisfaction regarding post-treatment state and integrative Korean medicine treatment through phone interview in 500 patients with MRI follow-up results before and after receiving conservative treatment for lumbar and cervical disc herniation at Jaseng Hospital of Korean Medicine.

02

Conditions studied

  • Lumbar Intervertebral Disc Displacement
  • Cervical Intervertebral Disc Displacement

Keywords

  • Magnetic Resonance Imaging
  • Patient Satisfaction
  • Numeric Rating Scale
03

In context

Intervertebral Disc Displacement

478 studies on the registry are indexed under Intervertebral Disc Displacement; 104 are open to participants now.

This study's enrollment of 505 is above the median of 100 across 121 observational studies indexed under Intervertebral Disc Displacement.

Browse Intervertebral Disc Displacement studies →

Lead sponsor

Jaseng Medical Foundation is the lead sponsor of 67 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Lumbar and/or cervical disc herniation patients with MRI results before and after receiving treatment at Jaseng Hospital of Korean Medicine between February 2012 and December 2015

Inclusion criteria

  • Lumbar and/or cervical disc herniation patients with baseline MRI and follow-up results after receiving treatment at Jaseng Hospital of Korean Medicine visiting between February 2012 and December 2015.
  • Participants giving informed written consent to use of medical records for academic means.

Exclusion criteria

Exclusion Criteria:

  • Participants refusing to participate in study or to respond to phone interview.
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
505 participants (actual)
Patient registry
No

Groups and cohorts

  • Lumbar/cervical disc herniation group

    Lumbar and cervical intervertebral disc herniation patients are administered integrative Korean medicine treatment consisting of herbal medicine, acupuncture, pharmacopuncture, bee venom pharmacopuncture, and Chuna manipulation.

    Drug: Herbal medicine · Procedure: Acupuncture · Procedure: Pharmacopuncture · Procedure: Bee venom pharmacopuncture · Procedure: Chuna manipulation

Interventions

  • DrugHerbal medicine

    Herbal medicine was administered 2-3 times daily in water-based decoction (120ml) and dried powder (2g) form (Ostericum koreanum, Eucommia ulmoides, Acanthopanax sessiliflorus, Achyranthes japonica, Psoralea corylifolia, Saposhnikovia divaricata, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, Glycine max, Atractylodes japonica).

    Also known as: Traditional herbal medicine

  • ProcedureAcupuncture

    Acupuncture treatment was administered 1-2 times daily using mainly proximal acupuncture points and Ah-shi points.

  • ProcedurePharmacopuncture

    Select herbal ingredients (Eucommia ulmoides cortex, Acanthopanax sessiliflorum cortex, Achyranthis bidentata radix, Saposhnikovia divaricata radix, Cibotium barometz rhizoma, Paeonia albiflora radix alba, Ostericum koreanum radix, Angelica pubescens radix, and Scolopendra subspinipes corpus (Paeonia albiflora twice the proportion of that of other ingredients)) were freeze dried into powder form after decoction, then diluted in water-for-injection and adjusted for acidity and pH. Pharmacopuncture was administered once daily at Hyeopcheok (Huatuo Jiaji, EX B2), Ah-shi points and local acupuncture points using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).

  • ProcedureBee venom pharmacopuncture

    Bee venom pharmacopuncture was administered only after confirming a negative response to hypersensitivity skin tests. Diluted bee venom (saline:bee venom ratio, 10,000:1) filtered for allergens was injected at 4-5 acupoints proximal to the painful site at the physician's discretion. Each acupuncture point was injected to a total of 0.5-1 cc using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).

    Also known as: Bee venom acupuncture

  • ProcedureChuna manipulation

    Chuna is a Korean version of spinal manipulation that incorporates spinal manipulation techniques for mobilization involving high-velocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement. Chuna manipulation was administered 3-5 times a week to pelvic, lumbar, thoracic, and cervical vertebrae at the physician's discretion.

    Also known as: Chuna spinal manipulation

06

What researchers measure

Primary outcomes

  1. Area of disc herniation at disc level most relevant to patient symptoms on MR sagittal and axial view

    Comparison of disc herniation in MRI between the baseline and post-treatment.

    Time frame: Change from baseline MRI (taken before treatment) at post-treatment completion MRI at average of 9 months

Secondary outcomes

  1. Level of disc degeneration at disc level most relevant to patient symptoms on MR sagittal and axial view

    Level of disc degeneration at disc level most relevant to patient symptoms on MR sagittal and axial view will be classified into 5 levels according to the method suggested by Pfirrmann et al.

    Time frame: Change from baseline MRI (taken before treatment) at post-treatment completion MRI at average of 9 months

  2. Level of disc herniation at disc level most relevant to patient symptoms on MR sagittal and axial view

    Level of disc herniation at disc level most relevant to patient symptoms on MR sagittal and axial view will be divided into 4 levels: protrusion, extrusion, sequestration, and migration

    Time frame: Change from baseline MRI (taken before treatment) at post-treatment completion MRI at average of 9 months

  3. Level of herniated disc migration in patients with disc migration at disc level most relevant to patient symptoms on MR sagittal and axial view

    Level of herniated disc migration in patients with disc migration will be categorized into 3 levels in accordance with the Komori classification

    Time frame: Change from baseline MRI (taken before treatment) at post-treatment completion MRI at average of 9 months

  4. Modic type change at vertebrae adjacent to disc level most relevant to patient symptoms on MR sagittal and axial view

    Modic type change at vertebrae adjacent to disc level most relevant to patient symptoms on MR sagittal and axial view will be classified into Modic types 0, 1, 2, and 3

    Time frame: Change from baseline MRI (taken before treatment) at post-treatment completion MRI at average of 9 months

  5. Modic type change location with regard to disc level most relevant to patient symptoms on MR sagittal and axial view

    Location of modic type change at the vertebrae adjacent to the herniated disc is classified by whether it is above, below, neither above nor below, or both above and below the disc level most relevant to patient symptoms on MR sagittal and axial view

    Time frame: Change from baseline MRI (taken before treatment) at post-treatment completion MRI at average of 9 months

  6. Pain NRS at site of chief complaint

    Low back pain NRS or neck pain NRS

    Time frame: Change from baseline MRI (taken before treatment) at post-treatment follow-up phone interview at average of 3 years

  7. Radiating pain NRS associated with site of chief complaint

    Radiating leg pain NRS or radiating arm pain NRS

    Time frame: Change from baseline MRI (taken before treatment) at post-treatment follow-up phone interview at average of 3 years

  8. Whether or not patient has been recommended for surgery regarding pain at site of chief complaint

    Whether or not patient has been recommended for surgery regarding pain at site of chief complaint will be recorded dichotomously

    Time frame: Post-treatment follow-up phone interview at average of 3 years

  9. Whether or not pain has recurred for 1 month or longer at site of chief complaint

    Whether or not low back pain, radiating leg pain, neck pain or radiating arm pain has recurred at site of chief complaint will be recorded dichotomously

    Time frame: Post-treatment follow-up phone interview at average of 3 years

  10. Type of treatment received, if any, for pain recurrence for 1 month or longer at site of chief complaint

    Type of treatment received, if any, for pain recurrence at site of chief complaint out of Korean medicine treatment, conventional nonsurgical treatment, or surgery will be recorded

    Time frame: Post-treatment follow-up phone interview at average of 3 years

  11. Whether or not patient was aware of possible spontaneous disc resorption at site of chief complaint at onset

    Whether or not patient is aware of possible spontaneous disc resorption at site of chief complaint will be recorded dichotomously

    Time frame: Post-treatment follow-up phone interview at average of 3 years

  12. Type of treatment patient would recommend to others as primary care

    Type of treatment patient would recommend to others out of surgical and nonsurgical treatment will be recorded

    Time frame: Post-treatment follow-up phone interview at average of 3 years

  13. Satisfaction with integrative Korean medicine treatment

    Satisfaction with integrative Korean medicine treatment will be recorded using a 5-point Likert scale: very dissatisfied, dissatisfied, slightly satisfied, satisfied, very satisfied

    Time frame: Post-treatment follow-up phone interview at average of 3 years

  14. Korean medicine treatment method perceived to be most effective

    Korean medicine treatment method perceived to be most effective out of herbal medicine, pharmacopuncture/bee venom pharmacopuncture, acupuncture, and Chuna manipulation will be recorded

    Time frame: Post-treatment follow-up phone interview at average of 3 years

07

Study locations

1 site
  • Jaseng Medical Foundation
    Bucheon, Gyeonggi Province 14598, Korea, Republic of
08

References and documents

Publications

  • Lee J, Kim J, Shin JS, Lee YJ, Kim MR, Jeong SY, Choi YJ, Yoon TK, Moon BH, Yoo SB, Hong J, Ha IH. Long-Term Course to Lumbar Disc Resorption Patients and Predictive Factors Associated with Disc Resorption. Evid Based Complement Alternat Med. 2017;2017:2147408. doi: 10.1155/2017/2147408. Epub 2017 Jul 9. PubMed 28769985 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02841163
Lead sponsor
Jaseng Medical Foundation
Responsible party
In-Hyuk Ha, KMD (Director, Jaseng Medical Foundation) — Principal investigator
First posted
Jul 22, 2016
Start date
Apr 2016
Primary completion
Oct 2016
Completion
Jan 2017
Last update
Jul 26, 2022

Study contacts

Joowon Kim, KMD, M.Sc.
principal investigator · Jaseng Medical Foundation

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion